from Airway Smooth Muscle Cells in Endothelial Growth Factor 165a Secretion Responsible for Increased Vascular Abnormal Histone Methylation Is

and Alan J. KnoxRachel L. Clifford, Alison E. John, Christopher E. Brightlinghttp://www.jimmunol.org/content/189/2/819doi: 10.4049/jimmunol.11036412012;J Immunol€2012; 189:819-831; Prepublished online 11 JuneReferenceshttp://www.jimmunol.org/content/189/2/819.full#ref-list-1This article cites 67 articles, 32 of which you can access for free at: Subscriptionshttp://jimmunol.org/subscriptionsInformation about subscribing to The Journal of Immunology is online at: Permissionshttp://www.aai.org/ji/copyright.htmlSubmit copyright permission requests at: Email Alertshttp://jimmunol.org/cgi/alerts/etocReceive free email-alerts when new articles cite this article. Sign up at:

[1]  J. Ko,et al.  Epigenetic mechanisms for silencing glutathione S‐transferase m2 expression by hypermethylated specificity protein 1 binding in lung cancer , 2011, Cancer.

[2]  W. Coward,et al.  Transcriptional regulation of inflammatory genes associated with severe asthma. , 2011, Current pharmaceutical design.

[3]  Mauro Giacca,et al.  Non-redundant functions of the protein isoforms arising from alternative splicing of the VEGF-A pre-mRNA , 2010, Transcription.

[4]  R. Schüle,et al.  Epigenetic regulation of cancer growth by histone demethylases , 2010, International journal of cancer.

[5]  Prerna Kumar,et al.  Interactive Roles of Ets-1, Sp1, and Acetylated Histones in the Retinoic Acid-dependent Activation of Guanylyl Cyclase/Atrial Natriuretic Peptide Receptor-A Gene Transcription* , 2010, The Journal of Biological Chemistry.

[6]  B. Hammock,et al.  DNA methylation of the promoter of soluble epoxide hydrolase silences its expression by an SP-1-dependent mechanism. , 2010, Biochimica et biophysica acta.

[7]  Yi Zhang,et al.  Active DNA demethylation: many roads lead to Rome , 2010, Nature Reviews Molecular Cell Biology.

[8]  M. Masuda,et al.  Cardiovascular , Pulmonary and Renal Pathology Early Growth Response-1 Induces and Enhances Vascular Endothelial Growth Factor-A Expression in Lung Cancer Cells , 2010 .

[9]  Philipp Bucher,et al.  KRAB–Zinc Finger Proteins and KAP1 Can Mediate Long-Range Transcriptional Repression through Heterochromatin Spreading , 2010, PLoS genetics.

[10]  C. Brightling,et al.  Airway smooth muscle proliferation and survival is not modulated by mast cells , 2010, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[11]  S. Chakrabarti,et al.  Transcriptional coactivator p300 regulates glucose-induced gene expression in endothelial cells. , 2010, American journal of physiology. Endocrinology and metabolism.

[12]  M. Mancarelli,et al.  The tumor suppressor gene KCTD11REN is regulated by Sp1 and methylation and its expression is reduced in tumors , 2010, Molecular Cancer.

[13]  Mingyao Liu,et al.  Kisspeptin-10, a KISS1-derived decapeptide, inhibits tumor angiogenesis by suppressing Sp1-mediated VEGF expression and FAK/Rho GTPase activation. , 2009, Cancer research.

[14]  H. Riethman,et al.  TERRA RNA binding to TRF2 facilitates heterochromatin formation and ORC recruitment at telomeres. , 2009, Molecular cell.

[15]  D. Bates,et al.  VEGF121b, a new member of the VEGFxxxb family of VEGF-A splice isoforms, inhibits neovascularisation and tumour growth in vivo , 2009, British Journal of Cancer.

[16]  H. Cedar,et al.  Linking DNA methylation and histone modification: patterns and paradigms , 2009, Nature Reviews Genetics.

[17]  Levon M. Khachigian,et al.  Sp1 Phosphorylation and Its Regulation of Gene Transcription , 2009, Molecular and Cellular Biology.

[18]  X. Fang,et al.  Sp-1 and c-Myc Mediate Lysophosphatidic Acid–Induced Expression of Vascular Endothelial Growth Factor in Ovarian Cancer Cells via a Hypoxia-Inducible Factor-1–Independent Mechanism , 2009, Clinical Cancer Research.

[19]  A. Knox,et al.  Novel regulation of vascular endothelial growth factor-A (VEGF-A) by transforming growth factor (beta)1: requirement for Smads, (beta)-CATENIN, AND GSK3(beta). , 2008, The Journal of biological chemistry.

[20]  Jennifer A. Mitchell,et al.  The Air Noncoding RNA Epigenetically Silences Transcription by Targeting G9a to Chromatin , 2008, Science.

[21]  S. Prasanna Kumar,et al.  Butyrate-induced phosphatase regulates VEGF and angiogenesis via Sp1. , 2008, Archives of biochemistry and biophysics.

[22]  B. O'connor,et al.  Induction of angiogenesis by airway smooth muscle from patients with asthma. , 2008, American journal of respiratory and critical care medicine.

[23]  Lena Claesson-Welsh,et al.  Claesson-Welsh L: Vascular endothelial growth factor (VEGF)-A165b is a weak in vitro agonist for VEGF receptor-2 due to lack of coreceptor binding and deficient regulation of kinase activity , 2022 .

[24]  T. Kimura,et al.  Zinc-Induced Formation of a Coactivator Complex Containing the Zinc-Sensing Transcription Factor MTF-1, p300/CBP, and Sp1 , 2008, Molecular and Cellular Biology.

[25]  M. Chopp,et al.  Ectopic decorin expression up‐regulates VEGF expression in mouse cerebral endothelial cells via activation of the transcription factors Sp1, HIF1α, and Stat3 , 2008, Journal of neurochemistry.

[26]  L. Hurley,et al.  The proximal promoter region of the human vascular endothelial growth factor gene has a G-quadruplex structure that can be targeted by G-quadruplex–interactive agents , 2008, Molecular Cancer Therapeutics.

[27]  P. Jagodziński,et al.  5-Aza-2'-deoxycytidine increases the expression of anti-angiogenic vascular endothelial growth factor 189b variant in human lung microvascular endothelial cells. , 2008, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[28]  Y. Song,et al.  Anti-inflammatory, anti-angiogenic and anti-nociceptive activities of Sedum sarmentosum extract. , 2008, Journal of ethnopharmacology.

[29]  I. Pavord,et al.  Vascular remodeling is a feature of asthma and nonasthmatic eosinophilic bronchitis. , 2007, The Journal of allergy and clinical immunology.

[30]  L. Cuppini,et al.  The histone deacetylase inhibitor ITF2357 has anti-leukemic activity in vitro and in vivo and inhibits IL-6 and VEGF production by stromal cells , 2007, Leukemia.

[31]  B. O'connor,et al.  Proangiogenic activity in bronchoalveolar lavage fluid from patients with asthma. , 2007, American journal of respiratory and critical care medicine.

[32]  V. Douet,et al.  DNA methylation and Sp1 binding determine the tissue-specific transcriptional activity of the mouse Abcc6 promoter. , 2007, Biochemical and biophysical research communications.

[33]  H. Stunnenberg,et al.  Identification of novel functional TBP‐binding sites and general factor repertoires , 2007, The EMBO journal.

[34]  Young Kyoon Kim,et al.  Expression of vascular endothelial growth factor and hypoxia-inducible factor in the airway of asthmatic patients. , 2006, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[35]  C. Brightling,et al.  Airway smooth muscle and mast cell-derived CC chemokine ligand 19 mediate airway smooth muscle migration in asthma. , 2006, American journal of respiratory and critical care medicine.

[36]  B. Murphy,et al.  Transcriptional Regulation of Uterine Vascular Endothelial Growth Factor during Early Gestation in a Carnivore Model, Mustela vison* , 2006, Journal of Biological Chemistry.

[37]  Abby L. Mulkeen,et al.  Post-transcriptional regulation of vascular endothelial growth factor: implications for tumor angiogenesis. , 2006, World journal of gastroenterology.

[38]  E. Walters,et al.  Increased vascular endothelial growth factor and receptors: relationship to angiogenesis in asthma. , 2006, American journal of respiratory and critical care medicine.

[39]  R. Panettieri,et al.  Interleukin-13 and interleukin-4 induce vascular endothelial growth factor release from airway smooth muscle cells: role of vascular endothelial growth factor genotype. , 2006, American journal of respiratory cell and molecular biology.

[40]  Salwa Bakr,et al.  A comparative study of two angiogenic factors: vascular endothelial growth factor and angiogenin in induced sputum from asthmatic children in acute attack. , 2006, Chest.

[41]  C. Seedhouse,et al.  Vascular Endothelial Growth Factor Induction by Prostaglandin E2 in Human Airway Smooth Muscle Cells Is Mediated by E Prostanoid EP2/EP4 Receptors and SP-1 Transcription Factor Binding Sites* , 2005, Journal of Biological Chemistry.

[42]  M. Abdelrahim,et al.  Cyclooxygenase-2 Inhibitors Decrease Vascular Endothelial Growth Factor Expression in Colon Cancer Cells by Enhanced Degradation of Sp1 and Sp4 Proteins , 2005, Molecular Pharmacology.

[43]  Jung Weon Lee,et al.  The FASEB Journal express article 10.1096/fj.04-3099fje. Published online May 26, 2005. ©2005 FASEB , 2022 .

[44]  J. Weis,et al.  Interleukin‐6 induces transcriptional activation of vascular endothelial growth factor (VEGF) in astrocytes in vivo and regulates VEGF promoter activity in glioblastoma cells via direct interaction between STAT3 and Sp1 , 2005, International journal of cancer.

[45]  E. Wang,et al.  TAF1 Histone Acetyltransferase Activity in Sp1 Activation of the Cyclin D1 Promoter , 2005, Molecular and Cellular Biology.

[46]  Martha R. Stampfer,et al.  Chromatin Inactivation Precedes De Novo DNA Methylation during the Progressive Epigenetic Silencing of the RASSF1A Promoter , 2005, Molecular and Cellular Biology.

[47]  Hiroshi Tanaka,et al.  Quantitative analysis of bronchial wall vascularity in the medium and small airways of patients with asthma and COPD. , 2005, Chest.

[48]  J. Pouysségur,et al.  Transcriptional regulation of the Vascular Endothelial Growth Factor gene--a concert of activating factors. , 2005, Cardiovascular research.

[49]  R. Day,et al.  Specificity of transcriptional regulation by the zinc finger transcription factors Sp1, Sp3, and Egr‐1 , 2005, Journal of cellular biochemistry.

[50]  P. Finn,et al.  Epigenetic approaches to cancer therapy. , 2004, Biochemical Society transactions.

[51]  Marina Ziche,et al.  VEGF165b, an Inhibitory Vascular Endothelial Growth Factor Splice Variant , 2004, Cancer Research.

[52]  M. Simon,et al.  Regulation of Transcription and Translation by Hypoxia , 2004, Cancer biology & therapy.

[53]  G. Wilson,et al.  Ref‐1/Ape is critical for formation of the hypoxia‐inducible transcriptional complex on the hypoxic response element of the rat pulmonary artery endothelial cell VEGF gene , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[54]  J. Yoshikawa,et al.  Role of microvascular permeability on physiologic differences in asthma and eosinophilic bronchitis. , 2004, American journal of respiratory and critical care medicine.

[55]  E. Goncharova,et al.  Vascular endothelial growth factor-induced secretion of fibronectin is ERK dependent. , 2004, American journal of physiology. Lung cellular and molecular physiology.

[56]  K. Wright,et al.  PRDI-BF1 recruits the histone H3 methyltransferase G9a in transcriptional silencing , 2004, Nature Immunology.

[57]  N. Ferrara,et al.  The biology of VEGF and its receptors , 2003, Nature Medicine.

[58]  K. Hirata,et al.  Increased levels of vascular endothelial growth factor in induced sputum in asthmatic patients , 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[59]  K. Hirata,et al.  Involvement of vascular endothelial growth factor in exercise induced bronchoconstriction in asthmatic patients , 2002, Thorax.

[60]  D. Gillatt,et al.  VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma. , 2002, Cancer research.

[61]  D. McDonald,et al.  Angiogenesis and remodeling of airway vasculature in chronic inflammation. , 2001, American journal of respiratory and critical care medicine.

[62]  A. Knox,et al.  Human airway smooth muscle cells secrete vascular endothelial growth factor: up‐regulation by bradykinin via a protein kinase C and prostanoid‐dependent mechanism , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[63]  T. Jenuwein,et al.  Structure-Function Analysis of SUV39H1 Reveals a Dominant Role in Heterochromatin Organization, Chromosome Segregation, and Mitotic Progression , 2000, Molecular and Cellular Biology.

[64]  J Bousquet,et al.  Asthma. From bronchoconstriction to airways inflammation and remodeling. , 2000, American journal of respiratory and critical care medicine.

[65]  J. Wilson,et al.  Increased vascularity of the bronchial mucosa in mild asthma. , 1997, American journal of respiratory and critical care medicine.

[66]  C. Koller,et al.  Mithramycin inhibits SP1 binding and selectively inhibits transcriptional activity of the dihydrofolate reductase gene in vitro and in vivo. , 1991, The Journal of clinical investigation.

[67]  J. Anderson,et al.  A comparison of the quantitative anatomy of the bronchi in normal subjects, in status asthmaticus, in chronic bronchitis, and in emphysema , 1969, Thorax.